Dr. Anand, Founding Director and CEO of Remidio, a pioneering brand combating preventable blindness and advancing eye care for broader health diagnostics, shares his insights ahead of the Union Budget 2025-26.
Recognizing Government Efforts
“The Government of India’s initiatives under the Ayushman Bharat Digital Mission deserve appreciation for their commitment to improving healthcare accessibility and quality,” says Dr. Anand.
AI Integration for Public Health
With India facing a massive burden of vision impairment—275 million affected, including 9.2 million with diabetic retinopathy, 11 million with glaucoma, and 36 million with AMD—AI-driven healthcare solutions can transform public health. Non-communicable diseases contribute to 60% of deaths in the country, making AI-powered retinal screening crucial in preventing fatal conditions like heart attacks, strokes, kidney diseases, and diabetes-related complications.
India’s Global Healthcare Leadership
India stands as a global leader in healthcare and medical tourism, attracting patients worldwide with its advanced infrastructure and cost-effective treatments.
Call for Government Support
Dr. Anand emphasizes the importance of AI-enabled diagnostics and early detection technologies. He urges the government to foster public-private partnerships and invest in research and development to enhance last-mile healthcare accessibility, strengthening India’s position as a global healthcare innovator.
